Pretreatment prediction of symptom response to proton pump inhibitor therapy.

about

Proton pump inhibitors for functional dyspepsia.

P2860

Q36300366-CF55A39E-30D0-495F-A9B6-EC6B27FE6D26

P2860

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

Item

http://www.wikidata.org/entity/Q39023140

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

@en

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

@nl

type

Item

label

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

@en

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

@nl

prefLabel

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

@en

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

@nl

P1476

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

@en

P2093

Akihito Nagahara

http://www.w3.org/2001/XMLSchema#string

Daisuke Asaoka

http://www.w3.org/2001/XMLSchema#string

Hiroto Miwa

http://www.w3.org/2001/XMLSchema#string

Hitoshi Sasaki

http://www.w3.org/2001/XMLSchema#string

Kenshi Matsumoto

http://www.w3.org/2001/XMLSchema#string

Mariko Hojo

http://www.w3.org/2001/XMLSchema#string

Sumio Watanabe

http://www.w3.org/2001/XMLSchema#string

Taro Osada

http://www.w3.org/2001/XMLSchema#string

Yuji Shimada

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of functional dyspepsia: a global perspective.

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.

Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.

Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.

Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.

Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Rese

Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.

Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.

Characteristics of Japanese patients with chronic gastritis and comparison with functional dyspepsia defined by ROME III criteria: based on the large-scale survey, FUTURE study.

P304

25-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JGH.12744

http://www.w3.org/2001/XMLSchema#string

P478

30 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25827800

http://www.w3.org/2001/XMLSchema#string

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

about

P2860

P2860

Pretreatment prediction of symptom response to proton pump inhibitor therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698